SAMANTHA OLEWNIK: Open Payments
NPI 1184936833 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 26 payments from 13 companies in 2025. Trend: 2023 $43 · 2024 $58 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $106 |
| Lilly USA, LLC | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $41 |
| Insulet Corporation | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
Products named: JARDIANCE, PREVNAR 20, VOQUEZNA, MOUNJARO, Omnipod, CAPLYTA, QULIPTA, Kerendia.
Industry payments across NY — which companies pay providers there.
